Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vivesto AB
VIVECurrent price
0.26 SEK
-0.0045 SEK (-1.71%)
Last closed
0.26 SEK
Company
www.vivesto.com
ISIN
SE0000722365
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Stockholm Exchange
Capitalization
141 505 315 SEK
Yield for 12 month
+34.36 %
1Y
3Y
5Y
10Y
15Y
VIVE
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Address: Gustav III:s Boulevard 46, Solna, Sweden, 169 73
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.73 SEKP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+1 015 001 SEK
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-10 655 999 SEK
Current Quarter
–
Last Quarter
–
Key Figures VIVE
1 year
3 years
5 years
10 years
EBITDA
-54 032 997 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.61 %
PEG Ratio
–
Return On Equity TTM
-43.42 %
Wall Street Target Price
10.73 SEK
Revenue TTM
6 612 000 SEK
Book Value
0.33 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
222.7 %
Dividend Yield
–
Gross Profit TTM
-2 289 000 SEK
Earnings per share
-0.18 SEK
Diluted Eps TTM
-0.18 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VIVE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VIVE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VIVE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
71.0151
Price Sales TTM
21.4013
Enterprise Value EBITDA
-1.1765
Price Book MRQ
0.7902
Financials VIVE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VIVE
For 52 weeks
0.16 SEK
0.65 SEK
50 Day MA
0.25 SEK
Shares Short Prior Month
–
200 Day MA
0.29 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart